Evidence map›Paper›PMID 28674052›Full record

ArticleAntimicrobial agents and chemotherapy2017

Characterization of a Large Antibiotic Resistance Plasmid Found in Enteropathogenic Escherichia coli Strain B171 and Its Relatedness to Plasmids of Diverse E. coli and Shigella Strains.

Tracy H Hazen, Jane Michalski, Sushma Nagaraj, Iruka N Okeke, David A Rasko

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Emerging Dissemination of blaMicrobiologyOpen · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Carbapenem-resistantEpidemiology and infection · 2022
    Article
  8. Invasiveness ofPathogens (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Diversity among blaScientific reports · 2018
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Tracy H HazenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jane MichalskiInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Sushma NagarajInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Iruka N OkekeFaculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
David A RaskoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA drasko@som.umaryland.edu.ORCID 0000-0002-7337-7154
University of Maryland, Baltimore · USUniversity of Ibadan · NG

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI DUNNING HOTOPP, JULIE · 2014 to 2023
$36.5M
NIAID NIH HHS U19 AI110820
6 · The paper itself

Abstract

Enteropathogenic

Indexed as

Anti-Bacterial AgentsAntiportersBacterial ProteinsBase SequenceDNA-Binding ProteinsDrug Resistance, Multiple, BacterialEnteropathogenic Escherichia coliEscherichia coli ProteinsGenome, BacterialMercuryMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsSequence Analysis, DNAShigella dysenteriaeSulfonamidesAnti-Bacterial AgentsAntiportersBacterial ProteinsDNA-Binding ProteinsEscherichia coli Proteinshha protein, E coliMercurySul1 protein, E coliSulfonamidestetA protein, BacteriaTetracyclineEPECEscherichia colimosaicplasmid

Identifiers

PMID28674052
PMCPMC5571317
OpenAlexW2724482577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.